Cypherpunk Technologies Inc. 是一家生物制药公司,致力于收购和开发用于治疗癌症的抗体疗法。公司总部位于马萨诸塞州剑桥。
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$20.9万
营业支出
2026-06-30
$468.9万
2026-03-31
$481.7万
2025-12-31
$510.3万
2025-09-30
$316.6万
净利润
2026-06-30
$3938.9万
2026-03-31
-$7716.6万
2025-12-31
$4020.3万
2025-09-30
-$330.3万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
-1.58K%
每股收益
2026-06-30
$-0.03
2026-03-31
$-0.46
2025-12-31
$0.92
2025-09-30
$-0.08
息税折旧摊销前利润
2026-06-30
-$468.9万
2026-03-31
-$8227.7万
2025-12-31
$4525.7万
2025-09-30
-$231.6万
有效税率
2026-06-30
4.77%
2026-03-31
6.21%
2025-12-31
11.16%
2025-09-30
-6.51%
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$0
$0
$0
$20.9万
营业支出
$468.9万
$481.7万
$510.3万
$316.6万
净利润
$3938.9万
-$7716.6万
$4020.3万
-$330.3万
净利润率
--
--
--
-1.58K%
每股收益
$-0.03
$-0.46
$0.92
$-0.08
息税折旧摊销前利润
-$468.9万
-$8227.7万
$4525.7万
-$231.6万
有效税率
4.77%
6.21%
11.16%
-6.51%
常见问题
CYPH represents a company whose core business operations determine its revenue and growth profile. To understand what CYPH does, review its official description, product lines, and customer base on the stock detail page. The nature of its business directly influences how the company earns money and how sensitive it may be to industry trends. This context helps investors assess whether CYPH fits their overall portfolio and research goals.
Recent performance for CYPH is shown through price changes over various time frames, including daily, weekly, and year-to-date movements. The stock detail page provides the latest data, which can change quickly based on market conditions. Comparing CYPH's recent returns with relevant benchmarks or sector peers can help investors understand relative strength or weakness. For the most current price and performance figures, check the live quote and chart on the page.
Valuation analysis for CYPH often involves examining metrics such as the price-to-earnings ratio, price-to-sales ratio, and enterprise value relative to EBITDA, if available. Comparing these multiples with industry averages or similar companies can provide context. Because valuation depends on current market data and financial results, review the latest figures displayed on the CYPH page. Also consider growth expectations and profitability trends when interpreting any metric.
Fractional share availability for CYPH depends on the brokerage platform. Many U.S. brokerages allow fractional investing, letting users buy a dollar amount rather than a whole share. This can make it easier to start a position in CYPH without purchasing a full share. Investors should check whether their specific broker supports fractional trading for CYPH and whether any additional fees or limitations apply.
Key risks for CYPH typically include business execution, competition, industry-specific challenges, and broader market volatility. Financial risks such as high debt levels or inconsistent profitability may also matter, depending on the company's situation. Regulatory or macroeconomic factors can affect operations and investor sentiment. Reviewing the risk factors disclosed in CYPH's filings and monitoring news can help investors understand the specific uncertainties facing the stock.
Start with CYPH's official investor relations materials, including annual reports, quarterly filings, and press releases. Financial data platforms and the stock detail page offer price charts, valuation metrics, and earnings history. News coverage and industry analysis can provide additional context. Organizing research around business model, financial health, competitive position, and valuation helps build a comprehensive view of CYPH.